Natera Inc
NASDAQ:NTRA
Natera Inc
Gross Profit
Natera Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Natera Inc
NASDAQ:NTRA
|
Gross Profit
$607.8m
|
CAGR 3-Years
40%
|
CAGR 5-Years
45%
|
CAGR 10-Years
35%
|
|
Abbvie Inc
NYSE:ABBV
|
Gross Profit
$36.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Gross Profit
$20.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Gross Profit
$19.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Gross Profit
$8.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
26%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Gross Profit
$11.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
18%
|
See Also
What is Natera Inc's Gross Profit?
Gross Profit
607.8m
USD
Based on the financial report for Mar 31, 2024, Natera Inc's Gross Profit amounts to 607.8m USD.
What is Natera Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
35%
Over the last year, the Gross Profit growth was 66%. The average annual Gross Profit growth rates for Natera Inc have been 40% over the past three years , 45% over the past five years , and 35% over the past ten years .